Navigation Links
The Female Health Company To Report First Quarter Operating Results on Wednesday, January 30, 2013
Date:1/23/2013

the African Regional Intellectual Property Organization (ARIPO), which includes Botswana, The Gambia, Ghana, Kenya, Lesotho, Malawi, Mozambique, Namibia, Sierra Leona , Sudan, Swaziland, Uganda, Tanzania, Zambia and Zimbabwe. FC2 patent applications are pending in various countries.  The FC2 Female Condom® is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy.  The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies.

"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:

The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings.  Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated.

For more information about The Female Health Company visit the Company's website at http://www.femalehealth.com and

SOURCE The Female Health Company
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
2. The Female Health Company Reports Second Quarter Operating Results
3. Attorneys for Class of Female VPs and SVPs Employed by PR Giant MSLGroup Clarify Companys Inaccurate Description of Federal Courts Recent Certification Ruling
4. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
5. The Female Health Company to Report FY2012 Operating Results on Tuesday, December 4, 2012
6. The Female Health Company Reports Record Fourth Quarter and FY2012 Operating Results
7. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
8. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
9. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... WELWYN GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, ... Akira Usui as a Consultant to augment the Company,s ... Asian territories. Mr Usui has more than 15 years ... pharmaceutical industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... th Annual  Healthcare Conference on Thursday, May 30, 2013, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
(Date:5/23/2013)... 23, 2013  A recently published clinical study conducted ... Texas , demonstrates that 3D mammography (breast tomosynthesis) ... The study, "Implementation of Breast Tomosynthesis ... led by Stephen L. Rose , ... American Journal of Roentgenology (AJR). The AJR ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
... ARBOR, Mich., April 7, 2011 Adeona Pharmaceuticals, Inc. (AMEX: ... serious central nervous system diseases, announced today that it has ... its common stock at approximately $2.0725 per share to a ... million in gross proceeds. The investor will also receive warrants ...
... April 7, 2011 Inhibitex, Inc. (Nasdaq: INHX ... of 11,463,415 shares of its common stock, at a purchase ... of $47 million. The net proceeds to Inhibitex from the sale ... offering expenses, are expected to be approximately $44 million.  Inhibitex ...
Cached Medicine Technology:Adeona to Raise $3.5 Million in Registered Direct Offering 2Adeona to Raise $3.5 Million in Registered Direct Offering 3Inhibitex Prices $47 Million Public Offering 2Inhibitex Prices $47 Million Public Offering 3
(Date:5/25/2013)... Acuity Games ’ innovative brain games have ... Word Hunt is available today, expanding it beyond its ... 2, Sudoku and Matchematics will roll out over the next ... lifetime brain fitness measurement have been re-optimized for the iPhone's ... brain fitness measurement in your pocket. What could be ...
(Date:5/25/2013)... 2013 IBISWorld estimates that revenue for the ... annual rate of 28.7% to $1.0 billion in the five ... 2002 and 2008, no new cell therapy products were introduced, ... growth during that period. In the years since, however, the ... This factor contributed to the industry's fast growth during the ...
(Date:5/25/2013)... Houston, Texas (PRWEB) May 25, 2013 ... more stressful than finals week. Increasingly, they are ... them stay awake and study. For more on ... Associates, a drug treatment facility, warns that students ... through finals” are at risk for developing a ...
(Date:5/25/2013)... Ayurveda is the traditional medicine of India. Translated ... While a medical science, its scope enters into the realms ... philosophy is that disease is the end result of living ... order to re-establish optimal health, we must discover where we ... style which brings us back into harmony. , The California ...
(Date:5/25/2013)... The current residents of Back2Basics - Long Term ... staff all came together Saturday, May 18th to celebrate the ... Cuisine, the residents got up to thank Roy Duprez, CEO ... road to recovery, and giving them a second chance at ... 2010 after realizing the need for a long-term facility. ...
Breaking Medicine News(10 mins):Health News:Acuity Games Apps Come to the iPhone 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2
... Conn., March 30 Anthem Blue Cross and Blue ... a Brand Excellence Award from the Blue Cross and ... Blue Cross and Blue Shield companies that excel in ... Shield Brand image."The Blue Cross and Blue Shield Brands ...
... an important building block of social interaction that prompts ... these children pay attention to physical relationships between movement ... the Yale School of Medicine report their results in ... , "Human infants are born in a fragile ...
... March 30 Golub Capital today announced that it ... equity to support the acquisition of Network Express, Inc., ... Street Capital. The combination of Ace Expediters, Inc., (which ... Network Express, Inc., creates the leading dedicated route logistics ...
... newborn is small, doctors should be aware, study says , , ... their due date have an increased risk of developmental delays ... thought to have little to no risk of long-term problems, ... "late pre-term") have as much as a 36 percent higher ...
... with Uncertain Origins Demonstrates Unmatched PerformanceREDWOOD CITY, Calif., March ... focused on oncology, announced today that the Journal ... the results of the Pathwork(R) Tissue of Origin Test ... a 1,550-Gene Expression Profile for Identification of Tumor Tissue ...
... PharmAthene, Inc. (NYSE Amex: PIP ), a ... threats, today reported operational and financial results for the ... December 31, 2008 and 2007, the Company reported revenues ... for the full year 2008 consisted primarily of contract ...
Cached Medicine News:Health News:Anthem Blue Cross and Blue Shield in Connecticut Receives Prestigious Brand Excellence Award 2Health News:Yale researchers discover mechanism for 2Health News:Golub Capital Provides Debt Financing to Support the Acquisition of Network Express, Inc., by Ace Expediters, Inc. 2Health News:Babies Born Only 2 to 3 Weeks Early May Face Development Delays 2Health News:Babies Born Only 2 to 3 Weeks Early May Face Development Delays 3Health News:Pathwork Tissue of Origin Test Validation Study Published in Journal of Clinical Oncology 2Health News:Pathwork Tissue of Origin Test Validation Study Published in Journal of Clinical Oncology 3Health News:PharmAthene Reports Year End 2008 Financial Results 2Health News:PharmAthene Reports Year End 2008 Financial Results 3Health News:PharmAthene Reports Year End 2008 Financial Results 4Health News:PharmAthene Reports Year End 2008 Financial Results 5Health News:PharmAthene Reports Year End 2008 Financial Results 6Health News:PharmAthene Reports Year End 2008 Financial Results 7
Long handle occluders are approximately 9 inches long....
Manual Lensmeter....
Lightweight, cordless lensmeter....
... 101 is well suited for measuring ... well as conventional spectacle lenses. It ... a full 90-degree inclination, which facilitates ... used in the vertical position. The ...
Medicine Products: